This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Humana (HUM) Receives a Hold from Wells Fargo

Tipranks - Tipranks - Fri Jun 5, 10:52AM CDT

In a report released today, Stephen Baxter from Wells Fargo maintained a Hold rating on Humana, with a price target of $227.00.

Claim 55% Off TipRanks

According to TipRanks, Baxter is a 3-star analyst with an average return of 1.6% and a 47.08% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Cencora, CVS Health, and McKesson.

In addition to Wells Fargo, Humana also received a Hold from Bank of America Securities’s Kevin Fischbeck in a report issued today. However, on the same day, Morgan Stanley assigned a Sell rating to Humana (NYSE: HUM).

See today’s best-performing stocks on TipRanks >>

Based on Humana’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $39.65 billion and a net profit of $1.19 billion. In comparison, last year the company earned a revenue of $32.11 billion and had a net profit of $1.24 billion

Read More on HUM:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).